Author： Dodel R.C.
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.14, Iss.3, 1998-09, pp. : 299-312
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Mitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease
Current Pharmaceutical Design, Vol. 20, Iss. 35, 2014-10 ,pp. :
Access to resources
Recommend
Treatment of Parkinsons Disease: Whats on the Horizon?
By Wu Stacy S.
CNS Drugs, Vol. 19, Iss. 9, 2005-01 ,pp. :
Subcutaneous Apomorphine: An Evidence-Based Review of its Use in Parkinsons Disease
By Dirk Deleu
Drugs & Aging, Vol. 21, Iss. 11, 2004-01 ,pp. :
Dopamine D3 Agonists in the Treatment of Parkinson&aposs Disease
Current Topics in Medicinal Chemistry, Vol. 15, Iss. 10, 2015-05 ,pp. :